Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 4, 2007, Pages 437-449

  D'Aguanno, Simona ^a,b   Del Boccio, Piero ^c   Bernardini, Sergio ^a,b   Ballone, Enzo ^c   Di Ilio, Carmine ^c   Federici, Giorgio ^a,b,d   Urbani, Andrea ^c  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

2 D electrophoresis; Cerebrospinal fluid; Dementia; Matrix assisted laser desorption ionisation time of flight mass spectrometry (MALDI TOF MS); Neurodegeneration; Proteomics

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

CANCER; CEREBROSPINAL FLUID ANALYSIS; DEMENTIA; ELECTROPHORESIS; HUMAN; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; PRIMARY MEDICAL CARE; PRION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; SAMPLE SIZE; SEPARATION TECHNIQUE; STATISTICAL ANALYSIS;

BIOLOGICAL MARKERS; CEREBROSPINAL FLUID PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34247335478     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.106     Document Type: Review

References (63)

1. Romeo MJ, Espina V, Lowenthal M, Espina BJ, Petricoin III EF, Lotta LA. CSF proteome: a protein repository for potential biomarker identification. Expert Rev Proteomics 2005;2:57-70.
2. Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr [review] 1994;14:495-533.
3. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease [review]. Lancet Neurol 2003;2:605-13.
4. Blennow K, Wallin A, Hager O. Low frequency of postlumbar puncture headache in demented patients. Acta Neurol Scand 1993;88:221-3.
5. Seehusen DA, Reeves MM, Fomin DA. Cerebrospinal fluid analysis. Am Fam Physician 2003;68:1103-8.
6. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. Philadelphia: W.B. Saunders, 1992.
7. Read SJ, Kurtz JB. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol 1999;37:1352-5.
8. Yuan X, Desiserio DM. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid. Proteomics 2005;5:541-50.
9. Lunding J, Midgard R, Vedeler CA. Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index. Acta Neurol Scan 2000;102:322-5.
10. Stich O, Graus, Rasiah C, Raurer S. Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration. J Neuroimmunol 2003;141:165-9.
11. Dorn C, Knobloch C, Kupka M, Morakkabati-Spitz N, Schmolling J. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report. Arch Gynecol Obstet 2003;269:62-5.
12. Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, et al. Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment. Clin Chem 2005;51:336-45.
13. Goldman D, Merril CR, Ebert MH. Two-dimensional gel electrophoresis of cerebrospinal fluid proteins. Clin Chem 1980;26:1317-22.
14. Sickmann A, Dormeyer W, Wortelkamp S, Woitalla D, Kuhn W, Meyer HE. Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 2000;21:2721-8.
15. Yuan X, Russel T, Wood G, Desiserio DM. Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis 2002;23:1185-96.
16. Finehout EJ, Franck Z, Lee KH. Towards two-dimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual. Electrophoresis 2004;25:2564-75.
17. Ogata Y, Charlesworth MC, Muddiman DC. Evaluation of protein depletion methods for the analysis of total-, phospho- and glycoproteins in lumbar cerebrospinal fluid. J Proteome Res 2005;4:837-45.
18. Hu Y, Malone PJ, Fagan AM, Townsend RR, Holtzman DM. Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. MCP 2005;4:2000-9.
19. Anderson LN, Anderson NG. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 1998;19:1853-61.
20. Maccarrone G, Milfay D, Birg I, Rosenhagen M, Holsboer F, Grimm R, et al. Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry. Electrophoresis 2004;25:2402-12.
21. Gianazza E, Arnaud P. A general method for fractionation of plasma proteins. Dye-ligand affinity chromatography on immobilized Cibacron blue F3-GA. Biochem J 1982;201:129-36.
22. Zhang J, Goodlet DR, Peskind ER, Qinn JF, Zhou Y, Wang Q, et al. Quantitative proteomic analysis of agerelated changes in human cerebrospinal fluid. Neurobiol Aging 2005;26:207-27.
23. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S, et al. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003;3:36-44.
24. Xie H, Rhodus NL, Griffin RJ, Carlis JV, Griffin TJ. A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol Cell Proteomics 2005;4:1826-30.
25. Moritz RL, Clippingdale AB, Kapp EA, Eddes JS, Ji H, Connolly NM, et al. Application of 2-D free-flow electrophoresis/ RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins. Proteomics 2005;5:3402-13.
26. Wessinger EM, Herteinstein B, Mischk H, Ganser A. Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis. Expert Rev Proteomics 2005;4:639-47.
27. Pelzing M, Neusub C. Separation techniques hyphenated to electrospray-tandem mass spectrometry in proteomics: capillary electrophoresis versus nanoliquid chromatography. Electrophoresis 2005;26:2717-28.
28. Fliser D, Wittke S, Mischak H. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes [review]. Electrophoresis 2005;26:2708-16.
29. Wittke S, Mischak H, Walden M, Kolch W, Radler T, Wiedemann K. Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches. Electrophoresis 2005;26:1476-87.
30. Carrette O, Burkhard PR, Hughes S, Hochstrasser DF, Sanchez JC. Truncated cystatin C in cerebrospiral fluid: technical (corrected) artefact or biological process? Proteomics 2005;12:3060-5.
31. Kallweit U, Bornsen OK, Kresbach GM, Widmer HM. Matrix compatible buffers for analysis of proteins with matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 1996:845-9.
32. Dubois F, Knochenmuss R, Steenvoorden RJ, Breuker K, Zenobi R. On the mechanism and control of salt-induced resolution loss in matrix-assisted laser desorption/ionization. Eur J Mass Spectrom 1996;2:2167-72.
33. Hage DS. Immunoassays wreviewx. Anal Chem 1995;67:455R-62.
34. Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS. Biomarkers: mining the biofluid proteome [review]. Mol Cell Proteomics 2005;4:409-18.
35. Westman A, Nilsson CL, Ekman R. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of proteins in human cerebrospinal fluid. Rapid Commun Mass Spectrom 1998;12:1092-8.
36. Tastet C, Lescuyer P, Diemer H, Luche S, van Dorsselaer A, Rabilloud T. A versatile electrophoresis system for the analysis of high- and low-molecular-weight proteins. Electrophoresis 2003;24:1787-94.
37. Xiao Z, Prieto D, Conrads TP, Veenstra TD, Issaq HJ. Proteomic patterns: their potential for disease diagnosis [review]. Mol Cell Endocrinol 2005;230:95-106.
38. Gobom J, Nordhoff E, Mirgorodskaya E, Ekman R, Roepstorff P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 1999;34:105-16.
39. Stensballe A, Andersen S, Jensen ON. Characterization of phosphoproteins from electrophoretic gels by nanoscale Fe(III) affinity chromatography with off-line mass spectrometry analysis. Proteomics 2001;1:207-22.
40. Larsen MR, Cordwell SJ, Roepstorff P. Graphite powder as an alternative or supplement to reversed-phase material for desalting and concentration of peptide mixtures prior to matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics 2002;2:1277-87.
41. Hagglund P, Bunkenborg J, Elortza F, Jensen ON, Roepstorff P. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J Proteome Res 2004;3:556-66.
42. Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, Thiery J. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-offlight mass spectrometry. Clin Chem 2005;51:973-80.
43. Laugesen S, Roepstorff P. Combination of two matrices results in improved performance of MALDI MS for peptide mass mapping and protein analysis. J Am Soc Mass Spectrom 2003;14:992-1002.
44. Schuerenberg M, Luebbert C, Eickhoff H, Kalkum M, Lehrach H, Nordhoff E. Prestructured MALDI-MS sample supports. Anal Chem 2000;72:3436-42.
45. Monti M, Principe S, Giorgetti S, Mangione P, Merlini G, Clark A, et al. Topological investigation of amyloid fibrils obtained from beta2-microglobulin. Protein Sci 2002;11:2362-9.
46. Carrette O, Demalte I, Scherl A, Yalkinoglu O, Corthals G, Burkhard P, et al. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 2003;3:1486-94.
47. Asgeirsson B, Haebel S, Thorsteinsson L, Helgason E, Gudmundsson O, Gudmundsson G, et al. Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68 - >Gln cystatin C variant in cerebrospinal fluids and monocyte cultures by MS. Biochem J 1998;329:497-503.
48. Ghiso J, Jensson O, Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci 1986;83:2974-8.
49. Nakanishi T, Sato T, Sakoda S, Yoshioka M, Shimizu. A modification of cysteine residue in transthyretin and a synthetic peptide: analyses by electrospray ionization mass spectrometry. Biochim Biophys Acta 2004;1698:45-53.
50. Villanueva J, Philip J, Chaparro CA, Li Y, Toledo-Crow R, DeNoyer L, et al. Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 2005;4:1060-72.
51. Davidsson P, Sjogren M, Andreasen N, Lindbjer M, Nilsson CL, Westman-Brinkmalm A, et al. Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. Brain Res Mol Brain Res 2002;109:128-33.
52. Dumont D, Noben JP, Raus J, Stinissen P, Robben J. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004;4:2117-24.
53. Hammack BN, Fung KY, Hunsucher SW, Duncan M, Burgoon MP, Owens GP, et al. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler 2004;10:245-60.
54. Dekker LJ, Boogerd W, Stockhammer G, Dalebout JC, Siccama I, Zheng P, et al. MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer. Mol Cell Proteomics 2005;4:1341-9.
55. Sanchez JC, Guillaume E, Lescuyer P, Allard L, Carette O, Scherl A, et al. Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics 2004;4:2229-33.
56. Righetti PG, Castagna A, Antonucci F, Piubelli C, Cecconi D, Campostrini N, et al. Proteome analysis in the clinical chemistry laboratory: myth or reality? Clin Chim Acta 2005;357:123-39.
57. Fonteh A, Harrington M. Presented at the 5th Siena meeting, from genome to Proteome, Italy, 2002.
58. Puchades M, Hansson SF, Nilsonn CL, Andreasen N, Blennow K, Davidsson P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res 2003;118:140-6.
59. Lovell MA, Xie C, Gabbita SP, Marksbery WR. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic Biol Med 2000;28:418-27.
60. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-10.
61. Sekine TK, Masuko-Hongo K, Matsui H, Asahara H, Takigawa M, Nishioka K, et al. Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:49-54.
62. Pounds S, Cheng C. Sample size determination for the false discovery rate. Bioinformatics 2005;23:4263-71.
63. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995;23:289-300.